A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 102.64
GOOG 581.13
MSFT 46.56
BAC 17.05
FB 78.29

Recently Added

BABA 87.17
DCOM 14.59
CPLP 9.82
MBLY 51.97
ARO 3.43

Gaining Speed

BABA 87.17
MBLY 51.97
DCOM 14.59
CPLP 9.82
SSYS 122.50

ZIOPHARM (ZIOP) Starts ZIO-201 Phase 2 in Germ Cell Tumors

ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) announced the start of a multicenter, single arm Phase 2 investigator-sponsored study of palifosfamide (ZIO-201) in patients with recurrent metastatic germ cell (testicular and ovarian) tumors who have relapsed on initial platinum-based therapy and high dose chemotherapy, or patients who are not eligible for...

Read More




Get Alerted When News Hits On This Stock - FREE!